WallStreetZenWallStreetZen

NASDAQ: CNSP
Cns Pharmaceuticals Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for CNSP

Based on 1 analyst offering 12 month price targets for Cns Pharmaceuticals Inc

Min Forecast
$20.00+226.26%
Avg Forecast
$20.00+226.26%
Max Forecast
$20.00+226.26%

Should I buy or sell CNSP stock?

Based on 1 analyst offering ratings for Cns Pharmaceuticals Inc.

Strong Buy
Strong Buy
1 analysts 100%
Buy
0 analysts 0%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their CNSP stock forecasts and price targets.

CNSP stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2025-09-12

1 of 1

Forecast return on equity

Is CNSP forecast to generate an efficient return?

Company
-158.59%
Industry
253.67%
Market
231.83%
CNSP's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is CNSP forecast to generate an efficient return on assets?

Company
-132.41%
Industry
95.01%
CNSP is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

CNSP earnings per share forecast

What is CNSP's earnings per share in the next 3 years based on estimates from 4 analysts?

Avg 1 year Forecast
-$6.46-101.51%
Avg 2 year Forecast
-$6.41-101.5%
Avg 3 year Forecast
-$25.34-105.94%

CNSP revenue forecast

What is CNSP's revenue in the next 2 years based on estimates from 3 analysts?

Avg 1 year Forecast
$0.0
Avg 2 year Forecast
$0.0

CNSP vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
CNSP$6.13$20.00+226.26%Strong Buy
ARTL$1.82$18.00+889.01%Strong Buy
PPCB$0.30N/AN/A
CMND$2.68N/AN/A
AIM$1.21$22.00+1,718.18%Buy
View Top Biotech Stocks

Cns Pharmaceuticals Stock Forecast FAQ

Is Cns Pharmaceuticals Stock a good buy in 2026, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NASDAQ: CNSP) stock is to Strong Buy CNSP stock.

Out of 1 analyst, 1 (100%) are recommending CNSP as a Strong Buy, 0 (0%) are recommending CNSP as a Buy, 0 (0%) are recommending CNSP as a Hold, 0 (0%) are recommending CNSP as a Sell, and 0 (0%) are recommending CNSP as a Strong Sell.

If you're new to stock investing, here's how to buy Cns Pharmaceuticals stock.

What is CNSP's earnings growth forecast for 2026-2028?

(NASDAQ: CNSP) Cns Pharmaceuticals's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 132.84%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 103.39%.

Cns Pharmaceuticals's earnings in 2026 is -$13,071,128.On average, 4 Wall Street analysts forecast CNSP's earnings for 2026 to be -$4,004,964, with the lowest CNSP earnings forecast at -$3,847,907, and the highest CNSP earnings forecast at -$4,122,757. On average, 4 Wall Street analysts forecast CNSP's earnings for 2027 to be -$3,973,330, with the lowest CNSP earnings forecast at -$3,817,513, and the highest CNSP earnings forecast at -$4,090,192.

In 2028, CNSP is forecast to generate -$15,716,164 in earnings, with the lowest earnings forecast at -$15,099,844 and the highest earnings forecast at -$16,178,404.

What is CNSP's revenue growth forecast for 2026-2027?

(NASDAQ: CNSP) Cns Pharmaceuticals's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 324.73%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 57.29%.

Cns Pharmaceuticals's revenue in 2026 is $0.On average, 3 Wall Street analysts forecast CNSP's revenue for 2026 to be $0, with the lowest CNSP revenue forecast at $0, and the highest CNSP revenue forecast at $0.

In 2027, CNSP is forecast to generate $0 in revenue, with the lowest revenue forecast at $0 and the highest revenue forecast at $0.

What is CNSP's forecast return on assets (ROA) for 2026-2028?

(NASDAQ: CNSP) forecast ROA is -132.41%, which is lower than the forecast US Biotechnology industry average of 95.01%.

What is CNSP's Price Target?

According to 1 Wall Street analyst that have issued a 1 year CNSP price target, the average CNSP price target is $20.00, with the highest CNSP stock price forecast at $20.00 and the lowest CNSP stock price forecast at $20.00.

The Wall Street analyst predicted that Cns Pharmaceuticals's share price could reach $20.00 by Sep 12, 2026. The average Cns Pharmaceuticals stock price prediction forecasts a potential upside of 226.26% from the current CNSP share price of $6.13.

What is CNSP's Earnings Per Share (EPS) forecast for 2026-2028?

(NASDAQ: CNSP) Cns Pharmaceuticals's current Earnings Per Share (EPS) is $426.82. On average, analysts forecast that CNSP's EPS will be -$6.46 for 2026, with the lowest EPS forecast at -$6.20, and the highest EPS forecast at -$6.65. On average, analysts forecast that CNSP's EPS will be -$6.41 for 2027, with the lowest EPS forecast at -$6.15, and the highest EPS forecast at -$6.59. In 2028, CNSP's EPS is forecast to hit -$25.34 (min: -$24.34, max: -$26.08).

What is CNSP's forecast return on equity (ROE) for 2026-2028?

(NASDAQ: CNSP) forecast ROE is -158.59%, which is considered weak.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.